Elizabeth Volkmann, MD, associate professor at UCLA, Director of the Scleroderma Program, and the codirector of UCLA's Connective Tissue Disease-Related Interstitial Lung Disease program, discusses treating...
Elizabeth Volkmann, MD, discusses her research into the association of the gut microbiome with systemic sclerosis, environmental influences on the microbiota, and advances in treating the disease.
Kristin Highland, MD, provides an overview of systemic sclerosis and associated interstitial lung disease, including symptoms and diagnosis, who's at risk, and new and upcoming treatments for this complex...
